Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Status unconfirmed

Conditions studied: Pancreatic Cancer

In brief

Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven Pancreatic cancer.

Key facts

Study ID

NCT01994681

Run by

Rauscher, Gregory E., M.D. PA

People needed

100

Starts

2013-10-01

Last updated by the study team

2013-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age from 18 years old
• Pancreatic cancer positive biopsy
• Before any treatment
• Signed Informed Patient Consent

You may not qualify if…

• Age under 18 years old
• Neoadjovant treatment
• Post surgery for Pancreatic cancer
• A history of any other cancer type, except skin cancer that is not melanoma
• Healthy Group
• Inclusion Criteria:
• Healthy patients
• No history of Pancreatic cancer
• Signed Informed Patient Consent
• Exclusion Criteria:
• History of Pancreatic cancer
• Pancreatic cancer background in the family
• A history of any other cancer type, except skin cancer that is not melanoma

Where it is running

• Hackensack University Medical Center — Hackensack, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.